Important Safety Information
Fr

Home
What is invasive meningococcal disease (IMD)?
What is Meningitis B?
About TRUMENBA
Risk Survey
Your Resources
FAQ

Are you or your child at risk of contracting `MenB`?

TRUMENBA is a vaccine to help prevent MenB (IMD caused by N. meningitidis serogroup B bacteria), for use in individuals aged 10 through 25 years.

Certain individuals are at increased risk of contracting MenB due to health conditions or environmental factors.

Complete this short questionnaire to determine if any of these risk factors apply to you/your child.

Once you have completed this questionnaire, a discussion guide with your answers will be generated. Bring it to your next visit with your healthcare professional to start the conversation about MenB vaccination.

Get started

Completed

question 1 of 6

1:Are you seeking information for yourself or your child?

Question1 *

Myself

My child

2:Are you/Is your child between 10 and 25 years of age?

Question2 *

Yes

No

Your/Your child’s age extends beyond the TRUMENBA indication.

3:Do you/Does your child attend any of the following? Choose all that apply.

Question3 *

Secondary school

College/University

Camp

Any other place where there are large groups of teens and young adults

None of the above

4:Have you/Has your child been vaccinated against IMD? Choose all that apply.

Question4*

Yes, with MenC

Yes, with MenACWY

I am not sure/I don’t remember

No

5:Have you/Has your child been vaccinated against MenB?

Question5 *

Yes

I am not sure/I don’t remember

No

6:Are any of the following circumstances or conditions applicable to you/your child? Choose all that apply.

Question6 *

Pregnancy

Breast-feeding

Previous reaction to MenB vaccine

Hematologic disorder

Other conditions that would be important to discuss with the healthcare professional regarding immunization

None of the above

Like all vaccines, TRUMENBA can cause side effects, although not everybody gets them. The most common side effects (reported in more than 1 in 10 people) after having TRUMENBA include headache, nausea, diarrhea, muscle pain, joint pain, redness, swelling and pain at the injection site, chills and fatigue (tiredness). Other common side effects (in more than 1 in 100 people) after having TRUMENBA are vomiting and fever ≥38°C. Side effects that have been reported during marketed use include allergic reactions and fainting. Tell your healthcare professional if you have, or your child has, a troublesome symptom or side effect not listed here, or one that becomes bad enough to interfere with daily activities. This is not a complete list of side effects.

For more information, please consult the Product Monograph or
call 1-800-463-6001.

TRUMENBA®

Home
What is invasive meningococcal
disease (IMD)?
What is Meningitis B?
About TRUMENBA
Risk Survey
Your Resources
FAQ

TRUMENBA is a registered trademark of Wyeth LLC, Pfizer Canada ULC, Licensee

© 2023 Pfizer Canada ULC Kirkland, Quebec H9J 2M5

PP-TRU-CAN-0081-EN

DIN: 02468751

Remember, a second dose is needed to complete your vaccination series with TRUMENBA.
Need a reminder?

Sign up Now!

Sign up to receive a vaccination reminder by email.

First NameE-mailE-mail ConfirmationProvince of residence

Date of your/your child’s first dose (mm/yyyy)

By providing your electronic address, you consent to receiving electronic communications containing information and updates from Pfizer Canada ULC relating to product related topics that might be of interest to you. You can withdraw your consent to receive such communications by following the instructions provided in the electronic communication. You can contact Pfizer Canada at any time at Pfizer Vaccines, P.O Box 800, Pointe-Claire – Dorval, Quebec H9R 4V2 or by phone at 1-888-637-5464.

I agree to the personal information consent.

Back

COLLECT AND PROCESS PERSONAL INFORMATION CONSENT

Personal information (such as your first and last name, and email address) collected from you to receive TRUMENBA vaccination reminders will be used by Pfizer Canada ULC ("Pfizer Canada") to email you communications on important updates, product information, as well as helpful lifestyle tips, health, wellness, and Pfizer-related programs from Pfizer Canada.
Your personal information may also be disclosed and/or transferred to a third party in the event of a proposed or actual purchase, sale (including a liquidation, realization, foreclosure or repossession), lease, merger, amalgamation or any other type of acquisition, disposal, transfer, conveyance or financing of all or any portion of Pfizer Canada or of any of the business or assets or shares of Pfizer Canada or a division thereof. Please note that sharing of personal information with service providers or disclosures to third parties may involve the storage or processing of personal information outside of Canada (including in the United States) where local privacy laws may require the disclosure of personal information to governmental authorities under circumstances that are different than those that apply in Canada.
By submitting your personal information, you consent to the manner of collection, use and disclosure of personal information as described above. If you later change your mind about such collection, use and disclosure for any reason, you may withdraw your consent, by contacting Pfizer Canada as set forth below. You have a right to access and correct your information, where required. If you have any inquiry concerning your personal information, please contact Pfizer Canada ULC at P.O. Box 800, Pointe-Claire – Dorval, Quebec H9R 4V2 or by phone at 1-888-637-5464. Further information about Pfizer Canada's privacy practices is available here.

A vaccine for meningitis B prevention.

Thank you for signing up for your
TRUMENBA vaccine reminder!